FDA OKs new flu vaccine from GlaxoSmithKline

08/18/2013 | Family Practice News · PMLive.com (U.K.)

The FDA has approved GlaxoSmithKline's Flulaval Quadrivalent vaccine for two A and two B strains of seasonal influenza. "Trivalent vaccines do reduce influenza risk, even in years when a vaccine strain-mismatch occurs, though quadrivalent influenza vaccines are the important next step in broadening strain coverage," said GSK's Dr. Leonard Friedland. The vaccine will be distributed for the coming flu season, and it is GSK's second quadrivalent flu vaccine to be approved in the U.S.

View Full Article in:

Family Practice News · PMLive.com (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY